Neuronetics updates subsidiary guarantees in loan

Neuronetics, Inc. entered into Amendment No. 4 to its existing Credit Agreement and Guaranty with Perceptive Credit Holdings IV, LP and other lenders.

Rhea-AI Filing Summary

Neuronetics, Inc. entered into Amendment No. 4 to its existing Credit Agreement and Guaranty with Perceptive Credit Holdings IV, LP and other lenders. This amendment changes how the company’s subsidiaries are required to join the credit facility as an “Obligor” and “Subsidiary Guarantor”, affecting which subsidiaries must guarantee the company’s debt under this agreement.

The amendment is part of the company’s ongoing relationship with Perceptive and adjusts the guarantee structure rather than creating a new financing arrangement. The full legal terms are contained in the amendment, which is filed as an exhibit to this report.

8-K Event Classification

2 items: 1.01, 9.01

2 items

Item 1.01 Entry into a Material Definitive Agreement Business

The company signed a significant contract such as a merger agreement, credit facility, or major partnership.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Neuronetics, Inc. (STIM) disclose in this 8-K?

Neuronetics, Inc. reported that it entered into Amendment No. 4 to its existing Credit Agreement and Guaranty with Perceptive Credit Holdings IV, LP and other lenders.

What does Amendment No. 4 change for Neuronetics, Inc. (STIM)?

Amendment No. 4 modifies the requirements for subsidiaries of Neuronetics, Inc. to join the credit facility as an “Obligor” and “Subsidiary Guarantor” under the existing agreement.

Is Amendment No. 4 a new financing arrangement for Neuronetics (STIM)?

The amendment updates the existing Perceptive Facility by changing subsidiary guarantor and obligor requirements, rather than establishing a new financing agreement.

Who is the lender under Neuronetics, Inc.’s amended credit facility?

The credit facility is with Perceptive Credit Holdings IV, LP as collateral agent, together with other lenders identified in the agreement.

Where can investors find the full text of Neuronetics (STIM) Amendment No. 4?

The complete Amendment No. 4 is filed as Exhibit 10.1 to this report and is incorporated by reference.

Does the amendment affect Neuronetics, Inc. common stock listing?

The company’s common stock, par value $0.01 per share, continues to trade on The Nasdaq Global Market under the symbol STIM.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/22/2026 - 07:30 AM EST Learn about SEC filing dates

false 0001227636 0001227636 2026-01-15 2026-01-15

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): January 15, 2026

NEURONETICS, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-38546		33-1051425
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

3222 Phoenixville Pike, Malvern, PA		19355
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (877) 600-7555

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of each exchange on which registered
Common Stock, $0.01 par value		STIM		The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01. Entry into a Material Definitive Agreement.

As previously disclosed, on July 25, 2024, Neuronetics, Inc. (the “Company”) entered into a Credit Agreement and Guaranty with Perceptive Credit Holdings IV, LP, (“Perceptive”) as collateral agent and other lenders defined in the agreement (the “Perceptive Facility”).

On January 15, 2026, the Company entered into Amendment No. 4 to Credit Agreement and Guaranty (the “Amendment”). The Amendment amends the Perceptive Facility to modify the requirements of subsidiaries joining as an “Obligor” and “Subsidiary Guarantor” thereunder.

The foregoing summary of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendment, a copy of which is filed as Exhibit 10.1 hereto and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number		Description
10.1		Amendment No. 4 to Credit Agreement and Guaranty, dated January 15, 2026
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

				NEURONETICS, INC.
Date: January 22, 2026				By:		/s/ Steven E. Pfanstiel
				Name:		Steven E. Pfanstiel
				Title:		EVP, Chief Financial Officer and Treasurer